A Study of MK-7240 in Healthy Participants (MK-7240-009)

A Randomized, Open-label, Parallel-group Study to Assess the Pharmacokinetic Bioequivalence of Subcutaneously-administered Tulisokibart Delivered by 2 Different Autoinjectors in Healthy Participants

The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.

Inclusion Criteria

The main inclusion criteria include but are not limited to the following:

• Has a body-mass index (BMI) between 18 and 32 kg/m^2

Exclusion Criteria

The main exclusion criteria include but are not limited to the following:

• Has a history of more than 1 episode of herpes zoster infection or history of disseminated herpes zoster infection
• Has a history of or current active tuberculosis (TB) infection or history of latent TB that was not fully treated